The ECLIPSE study was therefore designed to determine the underlying mechanisms of disease progression
and identify biomarkers that may serve as surrogate endpoints and therefore measures of disease progression.
ECLIPSE is a unique collaborative project between external experts and industry.
ECLIPSE is the first study to investigate novel endpoints in COPD disease progression.
ECLIPSE will provide a greater insight into patient needs and expand COPD disease understanding – causes, processes, patterns and progression.
The ECLIPSE study is leading the advancement of scientific and medical investigation into COPD.